124 related articles for article (PubMed ID: 3119647)
21. [The application of gonadotropin in treatment of male central hypogonadism].
Di FS; Cui YG; Jia Y
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):836-9. PubMed ID: 16316564
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin.
Menon DK
Fertil Steril; 2003 Jun; 79 Suppl 3():1659-61. PubMed ID: 12801577
[TBL] [Abstract][Full Text] [Related]
23. [A hormone assay as a therapeutic choice in male sterility].
Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
[TBL] [Abstract][Full Text] [Related]
24. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
25. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
26. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
[No Abstract] [Full Text] [Related]
27. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
28. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
McLachlan RI; Finkel DM; Bremner WJ; Snyder PJ
J Clin Endocrinol Metab; 1990 May; 70(5):1414-9. PubMed ID: 2110576
[TBL] [Abstract][Full Text] [Related]
29. Treatment of undescended testes with hMG and hMG plus hCG: clinical, hormonal and sonographic evaluation.
De Rosa G; Della Casa S; Corsello SM; Colabucci F; Rossodivita A; Ferdinandi A; Cecchini L
Ann Endocrinol (Paris); 1987; 48(6):468-72. PubMed ID: 2895604
[TBL] [Abstract][Full Text] [Related]
30. Testicular secretion after pulsatile human menopausal gonadotropin therapy in gonadotropin-releasing hormone agonist desensitized dysspermic men.
Adamopoulos DA; Nicopoulou S; Kapolla N; Vassilopoulos P; Karamertzanis M
Fertil Steril; 1994 Jul; 62(1):155-61. PubMed ID: 8005281
[TBL] [Abstract][Full Text] [Related]
31. [Combined therapy of male subfertility with HMG and HCG].
Petres J; Arbogast R
Fortschr Androl; 1974; 3():202-3. PubMed ID: 4469544
[No Abstract] [Full Text] [Related]
32. Initiation of spermatogenesis and successful in vitro fertilization in an infertile male with panhypopituitarism; superiority of pulsatile LH-RH over gonadotropins? A case report.
van de Berk D; Wijnberg M; van Dop PA
Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(2):153-7. PubMed ID: 1906412
[TBL] [Abstract][Full Text] [Related]
33. Patterns of serum FSH, LH and hCG after i.m. or i.v. administration of hMG during pituitary suppression.
Duijkers IJ; Hollanders HM; Willemsen WN; de Leeuw R; Vemer HM
Int J Fertil Menopausal Stud; 1995; 40(2):86-91. PubMed ID: 7599664
[TBL] [Abstract][Full Text] [Related]
34. [Gonadotrophin therapy (author's transl)].
Lunenfeld B; Olchovsky D; Tadir Y; Glezerman M
MMW Munch Med Wochenschr; 1981 May; 123(20):837-40. PubMed ID: 6792512
[TBL] [Abstract][Full Text] [Related]
35. Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males.
Badenoch DF; Waxman J; Boorman L; Sidhu B; Moore HD; Holt WV; Blandy JP
Acta Endocrinol (Copenh); 1988 Feb; 117(2):265-7. PubMed ID: 3132792
[TBL] [Abstract][Full Text] [Related]
36. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
[TBL] [Abstract][Full Text] [Related]
37. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
38. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
[TBL] [Abstract][Full Text] [Related]
39. Secondary treatment failure without anti-human chorionic gonadotropin antibody in a patient with Kallmann syndrome.
Kitahara S; Yoshida K; Ishizaka K; Higashi Y; Takagi K; Oshima H
Int J Urol; 1998 Jul; 5(4):398-400. PubMed ID: 9712456
[TBL] [Abstract][Full Text] [Related]
40. Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone.
Crottaz B; Senn A; Reymond MJ; Rey F; Germond M; Gomez F
Fertil Steril; 1992 May; 57(5):1034-43. PubMed ID: 1572471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
